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During the 7th annual follow-up of our cohort of homosex- 
ual men in 1989, we tested the hypotheses that infection with 
human immunodeficiency virus (HIV) may enhance the ex- 
pression of human papilloma virus (HPV) and that the devel- 
opment of anal epithelial abnormality is related to a biologic 
interaction between these two viruses. Overall, 41 (39%) of 
the 105 men had anal swabs positive for one or more eno- 
types of HPV 6/1 I, 16/18 or 31/33/35. Twenty-three (53k) of 
the 43 HIV-positive subjects harbored HPV compared to 18 
(29%) of the 64 HIV-negative subjects (p = 0.012). including 
higher prevalence rates for HPV genotypes 16/18 (p = O.Ol), 
6/1 I (p = 0.007). and 31/33/35 (p = 0.07). Multivariate logistic 
regression analysis of the HIV-positive subjects showed low 
CD4+ cell counts to be an independent risk factor for detec- 
tion of HPV (p = 0.04) and in particular for HPV genotypes 
31/33/35 (p = 0.02) and 611 I (p = 0.07). In contrast, similar 
analysis of the HIV-negative subset showed that a positive 
antibody test for syphilis was associated with HPV (p = 0.03). 
Anal epithelial abnormalities were found in 13 (14%) of 92 
technically adequate cytologic smears and were strongly as- 
sociated with detection of any HPV genotypes by the dot-blot 
method (p = O.Ol), and in particular with HPV genotypes 6/1 I 
(p = 0.001). None of I S  subjects with HPV detected only by 
PCR had anal epithelial abnormality. We propose a viral in- 
teraction model, in which HIV-related immune deficiency al- 
lows reactivation of HPV, with a subsequent or concomitant 
appearance of epithelial abnormality. 
The human papillomaviruses (HPV) include at least 60 ge- 
notypes and represent an important group of human pathogens 
(Koutsky et al., 1988). Although some genotypes of HPV may 
be considered benign, as they cause common dermal warts 
(Jablonska et al., 1985), genotypes 16, 18, 31, 33 and others 
have been implicated in the pathogenesis of squamous epithe- 
lial neoplasms (Ostrow et al., 1987), including cervical dys- 
plasia and invasive cervical cancer (Koutsky ei al., 1988), anal 
carcinoma (zur Hausen, 19896; Beckman et al., 1989), and 
perhaps bronchial carcinoma (Byme et al., 1987; Syrjanen et 
al., 1987). Furthermore, HPV infection of the ano-genital tract 
is frequent in both males and females, and some HPV are 
sexually transmitted (Koutsky et al., 1988). In males, HPV 
genotypes 6 and 11  have been detected in urethral specimens 
(Grussendorf-Conen et al., 1987), and HPV genotypes 2 and 5 
have been detected in semen samples (Ostrow et al., 1986). A 
high prevalence of HPV genotypes 16 and 33 has also been 
detected in colposcopically directed biopsies from lesions of 
penile intra-epithelial neoplasia (Barasso et al., 1989). 
The expression and detection of HPV are modulated by the 
immune status of the host. For example, the mild and transient 
immunodeficiency of pregnancy is associated with a concom- 
itant increase in HPV prevalence (Schneider et al . ,  1987). 
Similar trends have been seen with iatrogenic immune suppres- 
sion in renal allograft patients (Alloub et al., 1989) and in 
homosexual men with human immunodeficiency virus (HIV) 
infection (Frazer et al., 1986). Taken together, these observa- 
tions imply that HIV-associated immunosuppression may re- 
sult in an enhanced expression of HPV. Consequently, we 
evaluated anal HPV infection in a cohort of homosexual men to 
test the hypothesis that co-infection with HIV may enhance the 
expression of HPV. In addition, we evaluated whether the 
development of anal epithelial abnormality is related to a bio- 
logic interaction between these two viruses. 
MATERIAL AND METHODS 
Subjects and study design 
During May and June of 1982, we initiated a prospective 
cohort study, enrolling 245 homosexual and bisexual men who 
were consecutive patients of one primary care physician in 
Manhattan, NY, and 2 primary care physicians in Washington, 
DC. Enrolled subjects were reevaluated at approximately 
yearly intervals. Previous reports have provided details of en- 
rolment and follow-up procedures; demographic, drug use, and 
sexual practice data; and rates and risk factors for HIV and 
AIDS (Goedert et al., 1984, 1985a,b, 1987; Wiktor et al., 
1990). As sexual practices had markedly changed between 
1982 and 1989, we analyzed associations with levels of sexual 
activity and smoking (at least 1 cigarette per day) at time of 
enrolment (1982) questionnaire because we expected that the 
pre-1982 behavior would be more indicative of outcome. The 
current analysis included the 105 subjects from whom adequate 
samples for HPV testing were obtained during the 1989 eval- 
uation and included current (1989) CD4+ and CD8+ lympho- 
cyte counts determined by flow cytometry (Goedert et al.,  
1985~).  
Collection of specimens 
HIV, hepatitis B and syphilis antibodies were measured by 
standard techniques (Goedert et al., 1987). Epithelial cells 
from the transformation zone of the ano-rectal junction were 
collected by dacron swabs that were wetted in saline, directly 
inserted to the ano-rectal junction and gently rotated before 
being withdrawn. The first swab was smeared on a clean glass 
slide, sprayed immediately with a water-soluble fixative for 
exfoliative cytology (Clay Adam,  Becton Dickinson, Parsip- 
pany, NJ), and read later for cytologic abnormalities. Second 
and third swabs were collected similarly, transferred to trans- 
port media (Virapap, Life Technologies, Gaithersburg, MD), 
and kept at 4°C for 2 to 18 hr, when they were frozen at - 20°C 
until testing. 
Detection and typing of HPV DNA 
The presence of HPV was detected by dot blot hybridization 
and the polymerase-chain reaction (PCR). Commercially avail- 
able dot blot hybridization kits (Virapap and Viratype, Life 
Technologies) were used to screen for HPV and for detection 
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of specific HPV genotypes 611 1, 16, 18, 31, 33 and 35, fol- 
lowing the manufacturer's instructions. 
PCR was performed directly on the same virus transport 
medium. Following the protease digestion step of the dot blot, 
100 pl of the transport medium was precipitated with 100% 
ethyl alcohol and 1.2 M sodium acetate (PH 5.2)  overnight at 
-20°C. The precipitated DNA was dried under vacuum and 
redissolved in 100 pl of sterile distilled water. Prior to use for 
PCR, the target DNA was denatured by boiling at 100°C for 5 
min, followed by cooling for 15 min on ice. Specific primer 
pairs, corresponding to the E6 region of the HPV genomes, 
were designed to detect the presence of HPV 6, 11, 16, 18, 31 
and 33 sequences. Amplification was carried out in a DNA 
Thermal Cycler (Perkin-ElmedCetus, Emeryville, CA) for 30 
cycles. The reaction was carried out in 50 pl final volume 
consisting of 20 p1 of denatured target DNA, 2.5 units of the 
enzyme Taq polymerase and 50 picomole of HPV primer pairs 
in a PCR buffer. The composition of the PCR buffer was 10 
FM of each of dATP, dGTP, dCTP, 2.5 m~ magnesium chlo- 
ride, 10 m~ Tris-hydrochloride (PH 8.3), 50 m~ KCI, 0.1 
mg/ml of gelatin (Sigma, St Louis, MO, Catalog No 6507), 
0.45% Nonidet P40 (Sigma Catalog No N6507) and 0.45% 
Tween 20. The reaction cycle consisted of 3 steps-primer 
annealing for 30 seconds at 50"C, primer extension for 2 min 
at 37°C and denaturation for 1 min at 90°C. Based on our 
experience, we amplified HPV 16 and 18 sequences in one 
reaction mixture and HPV 6/11, 3 1 and 33 in a different reac- 
tion. The integrity of the amplification reaction was monitored 
by the incorporation of a primer pair for the hemoglobin gene 
in the tube containing HPV 16 and 18 primers. The amplified 
product was detected by hybridization with specific HPV 
probes at T,-20 (Caussy et al., 1988). 
Scoring criteria for HPV positivity 
No HPV-35 probe was available for PCR. Otherwise, dot 
blot and PCR were done on every sample for HPV genotypes 
6/11, 16, 18, 31, 33 and 35. A specimen was scored positive 
for a given genotype of HPV if it gave a positive hybridization 
signal with either the dot blot kit or the PCR reaction. For the 
purpose of analysis and in keeping with the known biologic 
properties of the HPV (Koutsky et al., 1988), we categorized 
the results of the HPV in the following genotypes: HPV 16/18, 
HPV 6/11 and HPV 31/33/35. "Any" HPV denotes the pres- 
ence of HPV 6/11, HPV 16/18 or HPV 31/33/35. To evaluate 
risk factors for HPV infection, samples giving positive signals 
in either the dot-blot or the PCR assay were considered posi- 
tive. To evaluate the effect of HPV as a risk factor for epithelial 
abnormality, results of the dot-blot and the PCR were consid- 
ered separately. 
Cytology 
Cytological smears were stained with the standard Papani- 
colaou technique and scored by a pathologist (J.G.) who had 
no prior knowledge of clinical or laboratory findings. Cells 
were examined for abnormal nuclear shape, size, chromatin 
pattern and overall nuclear staining (hyperchromasia). Smears 
were also examined for perinuclear cytoplasmic cavities char- 
acteristic of papillomavirus cytopathic effect. Smear cells 
showing at least 2 of the above nuclear abnormalities were 
considered to exhibit dysplasia, the grade of which was deter- 
mined by the amount of squamous differentiation in the 
involved cells, with less differentiation corresponding to 
higher-grade dysplasia. Smear cells showing just one nuclear 
abnormality as well as perinuclear cytoplasmic cavities (koi- 
locytosis) were considered to exhibit condylomatous changes. 
Smear cells showing just one nuclear abnormality and no other 
changes were classified as atypical. Smears with dysplasia, 
condylomatous changes or atypia were considered abnormal. 
All other smears that were adequately collected and fixed, 
including those with only anuclear squamous plaques, were 
considered normal. 
Statistical methods 
Data handling and statistical analyses were done by means of 
SAS software (SAS Institute, Cay ,  NC). Associations be- 
tween HPV and risk factors were determined by contingency 
table analysis, and significance testing was performed by the 
Chi square test, except that Fisher's exact test was used if any 
cell frequency was below 5. Student's t-test was used for con- 
tinuous variables, or the Wilcoxon unpaired rank sum test was 
used for variables that were not normally distributed. Agree- 
ment between the 2 detection methods was computed by Kappa 
statistics (Fleiss, 198 1). Multiple logistic regression was used 
to determine statistical independence of the effects of the pa- 
rameters we studied. Statistical significance was assessed by 
considering a p  value of 0.05 or less in a I-tail test. 
RESULTS 
The anal swabs of 41 (39%) of the 105 homosexual men 
were positive for one or more genotypes of HPV, including 22 
that were positive by both PCR and dot blot methods, 15 that 
were positive only by the PCR method, and 4 that were posi- 
tive only by the dot blot method. There was moderate overall 
agreement between the two methods (k = 0.58, p = 0.008). 
Risk factors and markers for HPV 
Detection of anal HPV was strongly associated with HIV 
infection, with one or more HPV genotypes detected in 23 
(53%) of 43 HIV-positive men compared to 18 (29%) of 62 
HIV-negative men (p = 0.01, Table I). As shown in Figure 1, 
each of the HPV genotypes was more frequent in HIV-positive 
than in HIV-negative men, including HPV 6/11 (33% vs. 11%, 
p = 0.007), HPV 16/18 (20% vs. 5%, p = 0.01), and HPV 
31/33/35 (39% vs. 16%,p = 0.07). With the dot blot method, 
2 men were co-infected with HPV 16/18 and 31/33/35, 3 others 
were co-infected with HPV 6/11 and 31/33/35, and 3 others 
were infected with all 3 HPV genotype groups. These 8 men 
were all HIV-positive. With the PCR method, 13 men were 
co-infected, including 4 who were HIV-negative. Using both 
tests, 22 men were infected with at least 2 genotypes of HPV. 
The prevalence of anal HPV was moderately associated with 
hepatitis B virus (p = 0.04) and weakly associated with syph- 
ilis (p = 0.19, Table I). HPV-positive men had had signifi- 
cantly more homosexual partners before 1982 (medians 25 vs. 
13.5 per year, p = 0.04) and tended toward more frequent 
unprotected receptive anal intercourse frequency (10-19 vs. 
5-9 per year, p = 0.12). In addition, HPV prevalence tended 
to be higher in those who had not completed college compared 
to those who had completed college (p = 0.07, Table I), but 
no significant associations were detected between HPV 
prevalence and city of enrolment, ethnic origin, age, or ciga- 
rette smoking. Subjects co-infected with HIV and HPV had 
slightly but not significantly lower CD4+ lymphocyte counts 
than did those with HIV only (p = 0.19, Table I); however, 
co-infection did not appear to affect CD8+ lymphocyte counts 
(p = 0.65). Among HIV-negative subjects, CD4+ and CD8+ 
lymphocyte counts were similar in HPV-positive and HPV- 
negative subjects (p 2 0.78). 
Stepwise logistic regression modelling was used to assess 
the relationship of each HPV genotype to the 5 following vari- 
ables: current CD4 + lymphocyte count, serological evidence 
of syphilis or hepatitis B virus infection, and historical number 
of male homosexual partners and frequency of receptive anal 
intercourse. Due to the strong associations between HPV and 
HIV status, separate models were run for HIV-positive and 
HIV-negative men. Among the HIV-positive subjects, lower 
numbers of CD4+ lymphocytes were independently associated 
216 CAUSSY ET AL. 
TABLE I - PREVALENCE OF ANY HPV GENOTYPE BY SELECTED 
DEMOGRAPHIC AND EXPOSURE CHARACTERISTICS 
Characteristic ofHPV (%)HPV pvalue' 
Number Number of 
neeative wsitive 
HIV status 
Positive 
Negative 
Positive 
Negative 
Positive 
Negative 
Number of homosexual 
partners in 1982 (median) 
Number of receptive 
anal intercourse acts 
in 1982 (median) 
Yes 
No 
Anti-hepatitis B core antigen 
Syphilis serologyz 
Completed college education 
City-New York 
Race-White 
Age (mean) 
Cigarette smoker-Yes 
HIV-positive subjects 
Washington 
Non-white 
-NO 
CD4 counts 
CD8 counts 
(mean cellslpl) 
(mean cells/kl) 
HIV-negative subjects 
CD4 counts 
CD8 counts 
(mean cells/kl) 
20 
44 
41 
23 
9 
54 
13.5 
5-9 
51 
13 
13 
51 
58 
6 
41 
20 
44 
630 
83 1 
1103 
23 (53%) 
18 (29%) 0.01 
33 (45%) 
7 (23%) 0.04 
10 (53%) 
31 (36%) 0.19 
25 0.04 
10-19 0.12 
26 (34%) 
15 (54%) 0.07 
11 (46%) 
30 (37%) 0.44 
35 (38%) 
6 (50%) 0.41 
40 0.56 
1 1  (35%) 
30 (41%) 0.63 
515 0.19 
760 0.65 
1151 0.78 
(mean cellslul) 631 637 0.95 
'Chi-square for proportions, t-test for means, or Wilcoxon rank sum test. 
-'Microhemagglutination for Treponema pallidwn. 
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FIGURE 1 - Prevalence of specific genotypes of human papilloma- 
viruses (HPV) detected in anal swabs from 105 homosexual men, by 
the subjects' human immunodeficiency virus (HIV) status. 
with the detection of one or more HPV genotypes (p = 0.04), 
after adjusting for the number of sexual partners, anal inter- 
course and syphilis (Table II). This adjusted association with 
CD4 counts was strongest with HPV genotypes 31/33/35 
(p = 0.02), weaker with HPV genotypes 6/11 (p = 0.07), 
TABLE II - MULTIVARIATE ANALYSIS OF RISK FACTORS FOR HPV 
GENOTYPES AMONG HIV-POSITIVE SUBIECTS 
xz ' p-values Independent Dependent variables variables 
One or more 
HPV genotypes 
HPV 6/11 
genotypes 
HPV 16/18 
genotypes 
HPV 31/33/35 
genotypes 
CLM counts 
Sexual partners 
Syphilis 
Frequency of 
receptive anal 
intercourse 
CD4 counts 
Sexual partners 
Syphilis 
Frequency of 
receptive anal 
intercourse 
CD4 counts 
Sexual partners 
Syphilis 
Frequency of 
receptive anal 
intercourse 
CD4 counts 
Sexual partners 
Syphilis 
Frequency of 
receptive anal 
intercourse 
4.46 .1 
0.02 
0.28 
0.18 
3.32 5- 
0.38 
0.18 
0.02 
0.01 
0.62 
0.55 
2.68 
5.32 
1.40 
0.02 
0.61 
O N 2  
0.89 
0.59 
0.67 
0.07 
0.54 
0.67 
0.89 
0.93 
0.43 
0.46 
0.10 
0.022 
0.23 
0.89 
0.43 
'Associated with the independent variable for relative coneibution to the model. 
Arrows indicate direction of associations.-'Statistically significant at p = 0.05. 
Separate models were run for each viral genotype using continuous independent 
variables except for syphilis (antibody to Treponema pallidurn) and hepatitis B virus 
(antibody to hepatitis B core antigen). 
and not detectable with HPV genotypes 16/18 (p = 0.93, Ta- 
ble 11). The only other independent association in the HIV- 
positive men was a trend toward higher frequency of anal 
intercourse with HPV 16/18 (p = 0.10, Table II), which was 
stronger (i .e. ,  p < 0.01) after serological evidence of hepatitis 
B virus was added to this model. Among the HIV-negative 
men, a multivariate logistic regression model demonstrated a 
significant association between detection of any HPV and a 
positive syphilis serology (p = 0.03) but not with CD4 
counts, anal sex or sexual partners (p > 0.18). This multivari- 
ate association was particularly strong for syphilis with HPV 
31/33/35 (p = 0.01). 
Risk factors for anal epithelial abnormality 
Thirteen (12%) of the anal cytologic smears obtained were 
technically unsatisfactory and could not be interpreted. Of the 
92 smears that could be interpreted, 13 (14%) demonstrated 
epithelial abnormality, including 1 with dysplasia, 3 with 
condylomatous changes, and 9 with atypia. Nine (24%) of the 
37 HIV-positive men had epithelial abnormality, compared to 
4 (7%) of the 55 HIV-negative men (p = 0.03). Cigarette 
smoking had a weaker association, with epithelial abnormality 
in 6 (21%) of 28 smokers compared to 7 (11%) of 65 non- 
smokers (p = 0.15). 
The prevalence of anal epithelial abnormality was dependent 
on both the HPV genotypes and the detection method used. 
Thus, when the dot blot technique was used, anal epithelial 
abnormality was strongly associated with HPV (p = 0.012, 
Table III), particularly with genotypes 6/11 (p = 0.0014) and 
to a lesser extent with genotypes 31/33/35 (p = 0.063). How- 
ever, when HPV was detectable by the PCR method only, none 
of the 15 subjects (4 HIV-positive and 11 HIV-negative) had an 
epithelial abnormality. Six men with mild abnormalities (a- 
typia) were not positive in the HPV dot blots. Three of these 
men were cigarette smokers. On further assessment of statis- 
tical independence by the logistic regression technique, anal 
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TABLE III - ASSOCIATION BETWEEN ABNORMAL ANAL CYTOLOGY AND 
DOT-BLOT METHOD OF DETECTTNG HPV IN 92 HIV-POSITIVE OR -NEGATIVE 
HOMOSEXUAL MEN 
m-negative HIV-positive All 92 men 
HPV by men men 
method’ 
dot blot Anal cytology Anal cytology Anal cytology 
Normal Abnormal Normal Abnormal Normal Abnormal 
AnyHPV - 46 3 18 3 64 6 + 5 1 10 6 15 72 
HPV 6/11 - 49 3 24 4 73 7 
+ 2  1 4 5  6 63 
HPV 16/18 - 50 4 23 7 73 1 1  
+ 1  0 5 2  6 2 
HPV 
31/33/35 - 49 4 22 5 71 9 
+ 2  0 6 4  8 44 
‘By PCR, 18 subjects (5 with epithelial abnormality) were positive for HF’V 6/11; 
12 (1 with epithelial abnormality) for HF’V 16/18; 16 (1 with epithelial abnormality) 
for HPV 31/33/35; and 34 (6 with epithelial abnormality) for any HF’V.-*p = 0.012 
by Fisher’s exact te~t.-~p = 0.0014 by Fisher’s exact t e ~ t . - ~ p  = 0.063 by Fisher’s 
exact test. 
epithelial abnormality was strongly related to dot-blot detection 
of HPV 6/11 (p < 0.002), very weakly related to smoking 
(p = 0.07 to 0.13), and unrelated (after adjustment for HPV 
status) to CD4 counts 0, > 0.3) or HIV status (p > 0.3). 
DISCUSSION 
In our study of homosexual men, 39% had one or more 
genotypes of HPV detected by molecular analyses of anal 
swabs and 14% had epithelial abnormality on anal cytologic 
smears. In the presence of HIV infection, the prevalence rates 
of all HPV genotypes tested were increased, and in particular 
the prevalence rates of HPV genotypes 31/33/35 and 611 1 were 
inversely related to CD4+ lymphocyte counts. Furthermore, 
anal epithelial abnormality was more frequent with certain 
HPV genotypes as detected by the dot blot method. 
Morphologic features indicative of HPV infection have been 
previously noted in anal intra-epithelial neoplasia (AIN) of 
HIV-infected men (Croxton et al., 1984). Scholefield et al. 
(1989) using DNA hybridization on colposcopically-directed 
anal biopsies, have reported that HPV genotypes 6/11 were 
associated with low-grade AIN and HPV genotypes 16/18 with 
high-grade AIN, similar to the pattern observed in cervical 
intra-epithelial lesions (Crum et al., 1985). Cytologic evidence 
of HPV infection in HIV-infected homosexual men has also 
been noted (Frazer et al., 1986). By a combination of molec- 
ular and cytologic methods, we have been able to confirm the 
presence of, and to further evaluate the relationships between, 
specific HPV genotypes and abnormal anal cytology. We 
found that the prevalence of anal epithelial abnormality was 
related to genotypes 6/11 and to a lesser extent with HPV 
genotypes 31/33/35. It is noteworthy that these associations 
were strongest for the dot-blot detection method, which re- 
quires a high copy number of HPV genomes (Caussy et al., 
1988), and weakest for the PCR method, which does not. As 
there were no high-grade AIN lesions in our population, our 
observation on HPV 6/11 and anal epithelial abnormality is 
consistent with that of Scholefield et al. (1989). 
HPV infections may be latent (Ferenczy et al., 1985) and the 
factors triggering reactivation are not fully defined although 
immune competence is clearly involved. For instance, the tran- 
sient immune deficiency associated with pregnancy (Schneider 
et al., 1987) and iatrogenic immune deficiency of renal trans- 
plantation can lead to HPV reactivation (Alloub et al., 1989; 
Rudlinger er al., 1989). Similarly, we noted that the preva- 
lence of HPV increased inversely with the number of CD4+ 
lymphocytes among HIV-infected homosexual men. Since our 
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observations suggest that epithelial abnormality is related to 
active replication of HPV and an increased number of copies of 
its genome, we postulate that HIV-related immune deficiency 
is not directly related to anal epithelial abnormality but rather 
may permit reactivation of dormant HPV (Fig. 2 ) .  In this 
model, epithelial abnormality is a consequence of actively rep- 
licating HPV, with perhaps some independent contribution 
from smoking. Our model provides a general framework for 
understanding the role of immune suppression in the reactiva- 
tion of dormant HPV infection to induce cytologic abnormal- 
ity. 
Anal carcinoma is a relatively rare disease (Young et al., 
1981) and the etiological role of HPV in the genesis of anal 
cancer (zur Hausen, 1989a), as in cervical cancer (Caussy et 
al., 1990), has been difficult to substantiate epidemiologically. 
If epithelial abnormality is a pre-malignant condition, then one 
might expect an increase in the number of cases of anal cancer 
among those at high risk of AIDS. In fact, the frequency of 
anal cancers among never-married men between 20 and 49 
years of age increased 10-fold in Manhattan, New York City 
from 0.3 cases per year before 1977 to 3 cases per year be- 
tween 1979 and 1985 (Biggar et al., 1989). In addition, in- 
creased risks have been noted for homosexual men (Daling et 
al., 1987; Holly et al., 1989). 
Early studies linking HPV to anal carcinoma have employed 
cytologic (Holly et al., 1989) or immunochemical methods 
(Gal et al., 1987) that could not implicate the particular ge- 
notypes of HPV involved. A population-based case-control 
study did note that HPV 16/18, 31 and even 6/11 were asso- 
ciated with anal cancer (Beckman et al., 1989). HPV geno- 
types 16/18, 31, 33 and 35 have been reported in cervical 
dysplasia, cervical carcinoma and anogenital carcinoma and 
are likely to be involved in the genesis of anal carcinoma 
(Beaudenon et al., 1986; Lorincz et al., 1986, 1987; zur 
Hausen, 1989). The role of HPV 611 1 in squamous-cell carci- 
noma remains controversial, since infection with HPV 611 1 is 
associated with concomitant infection with other genital HPV 
SEXUAL EXPOSURE 
-,.,,,I/ \-, 
$ * 
H IV HPV (latent) 
IMMUNE 4 -&I 
DEFICIENCY 
HPV (active) 
1 < EPITHELIAL 
ABNORMALITY 
d. 
4 
d. 
CANCER 
FIGURE 2 - Proposed model of the relationships of human immu- 
nodeficiency virus (HIV) infection, HIV-related immune deficiency, 
human papillomavirus (HPV) infection and activation, and epithelial 
abnormality. Immune deficiency appears to foster the activation of 
HPV, with concomitant or subsequent appearance of epithelial abnor- 
mality. Cigarette smoking may also contribute to cytologic abnormal- 
ity, and the precise relationship of abnormality to cancer is unknown. 
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genotypes (zur Hausen, 1989~).  Nonetheless, genotypes of 
HPV 6/11 have been identified in a variety of squamous-cell 
carcinomas (Byrne et al., 1987; Kasher and Roman, 1988; 
Rando et al., 1986) and the oncogenic potential of this geno- 
type should not be dismissed. Our findings indicate the need 
for further study of HPV genotypes in the pathogenesis of anal 
carcinoma. 
Retrospective case-control and cross-sectional studies can- 
not unambiguously distinguish etiologically relevant infection 
with HPV from opportunistic infection of an established cancer 
(Caussy et al., 1990; Muiioz et al., 1988). Our finding of a 
high prevalence of HPV infection in a cohort not selected for 
the presence of anal carcinoma or epithelial abnormality, in 
addition to the association of certain genotypes with epithelial 
abnormality, support the hypothesis that one or more geno- 
types of HPV are etiologically involved in the pathogenesis of 
anal carcinoma and are not merely another opportunistic agent 
in HIV-infected subjects. However, only prospective follow- 
up of these types of cohorts will unambiguously establish 
which specific genotypes of HPV are directly or indirectly 
predictive of anal cancer onset. 
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